Unknown

Dataset Information

0

Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE).


ABSTRACT: AIMS:Ischaemic heart failure (IHF) patients have a poor prognosis even with current guideline-derived therapy. Intramyocardial injections of autologous or allogeneic mesenchymal stromal cells might improve cardiac function leading to better clinical outcome. METHODS:The SCIENCE (Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE) consortium has initiated a Horizon 2020 funded multicentre phase II study in six European countries. It is a double-blind, placebo-controlled trial testing the safety and efficacy of allogeneic Cardiology Stem Cell Centre Adipose-derived Stromal Cells (CSCC_ASC) from healthy donors or placebo in 138 symptomatic IHF patients. Main inclusion criteria are New York Heart Association class II-III, left ventricular ejection fraction ?300?pg/mL. Patients are randomized in a 2:1 pattern to receive intramyocardial injections of either CSCC_ASC or placebo. CSCC_ASC and placebo treatments are prepared centralized at Rigshospitalet in 5?mL vials as an off-the-shelf product. Vials are distributed to all clinical partners and stored in nitrogen vapour tanks ready to be used directly after thawing. A total of 100?×?106 CSCC_ASC or placebo are injected directly into viable myocardium in the infarct border zone using the NOGA XP system (BDS, Cordis, Johnson & Johnson, USA). Primary endpoint is a centralized core-laboratory assessed change in left ventricular end-systolic volume at 6-month follow-up measured by echocardiography. The trial started in January 2017, 58 patients were included and treated until July 2018. CONCLUSION:The SCIENCE trial will provide clinical data on efficacy and safety of intramyocardial cell therapy of allogeneic adipose-derived stromal cells from healthy donors in patients with IHF.

SUBMITTER: Paitazoglou C 

PROVIDER: S-EPMC6774320 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE).

Paitazoglou Christina C   Bergmann Martin W MW   Vrtovec Bojan B   Chamuleau Steven A J SAJ   van Klarenbosch Bas B   Wojakowski Wojtek W   Michalewska-Włudarczyk Aleksandra A   Gyöngyösi Mariann M   Ekblond Annette A   Haack-Sørensen Mandana M   Jaquet Kai K   Vrangbaek Karsten K   Kastrup Jens J  

European journal of heart failure 20190220 8


<h4>Aims</h4>Ischaemic heart failure (IHF) patients have a poor prognosis even with current guideline-derived therapy. Intramyocardial injections of autologous or allogeneic mesenchymal stromal cells might improve cardiac function leading to better clinical outcome.<h4>Methods</h4>The SCIENCE (Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE) consortium has initiated a Horizon 2020 funded multicentre phase II study in six European countries. It is a double-blind, placebo-controlled tr  ...[more]

Similar Datasets

2010-05-16 | E-GEOD-14338 | biostudies-arrayexpress
2010-05-16 | E-GEOD-14327 | biostudies-arrayexpress
2010-01-05 | GSE14338 | GEO
2010-01-05 | GSE14327 | GEO
| S-EPMC7092733 | biostudies-literature
| S-EPMC5129079 | biostudies-literature
| S-EPMC5353290 | biostudies-literature
| S-EPMC5412707 | biostudies-literature
| S-EPMC9996968 | biostudies-literature
| S-EPMC5746641 | biostudies-literature